Publications by authors named "Ana M Lopez"

Article Synopsis
  • Hispanic cancer patients and survivors face higher pain levels and more barriers to pain management than non-Hispanic individuals, emphasizing the need for better support.
  • A study analyzed treatment expectations for integrative therapies like acupuncture and massage, finding that Hispanic participants had significantly higher expectations of benefit from these treatments compared to their non-Hispanic counterparts.
  • The research suggests that pain management strategies should consider these ethnic differences in expectations to improve treatment outcomes and address disparities in pain management among different populations.
View Article and Find Full Text PDF

Background: Current understanding of the mechanism of action of the pericapsular nerve group (PENG) block is primarily based on cadaver studies. We performed an imaging study in patients undergoing hip surgery to enhance the understanding of the analgesic mechanisms following a PENG block.

Materials And Methods: 10 patients scheduled for hip surgery received an ultrasound-guided PENG block with 18 mL of 0.

View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is the most common primary malignancy in the liver and is the third cause of cancer-related death worldwide. Surveillance with abdominal ultrasound should be offered to individuals at high risk for developing HCC. Accurate diagnosis, staging, and liver function are crucial when determining the optimal therapeutic approach.

View Article and Find Full Text PDF

Context And Objectives: Cancer centers are increasingly providing complementary medicine as part of an emerging discipline termed 'integrative oncology' (IO). The present study explored factors associated with disparities in referral and adherence to a freely-provided IO program.

Methods: The databases of three oncology centers in northern Israel were searched retrospectively for chemotherapy-treated oncology patients eligible for referral by their oncology healthcare professionals to an integrative physician (IP) consultation.

View Article and Find Full Text PDF

Complex IrH(PPr) () activates two different σ-bonds of 3-phenoxy-1-phenylisoquinoline, 2-(1-benzimidazol-2-yl)-6-phenylpyridine, 2-(1-indol-2-yl)-6-phenylpyridine, 2-(2-hydroxyphenyl)-6-phenylpyridine, -(2-hydroxyphenyl)-'-phenylimidazolylidene, and 1,3-di(2-pyridyl)-4,6-dimethylbenzene to give IrH{κ--[CH-isoqui-O-CH]}(PPr) (), IrH{κ--[NBzim-py-CH]}(PPr) (), IrH{κ--[Ind-py-CH]}(PPr) (), IrH{κ--[CH-py-CHO]}(PPr) (), IrH{κ--[CH-Im-CHO]}(PPr) (), and IrH{κ--[py-CHMe-CHN]}(PPr) (), respectively. The activations are sequential, with the second generally being the slowest. Accordingly, dihydride intermediates IrH{κ--[CH-isoqui-O-CH]}(PPr) (), IrH{κ--[NBzim-py-CH]}(PPr) (), IrH{κ--[Ind-py-CH]}(PPr) (), and IrH{κ--[py-CHMe-py]}(PPr) () were characterized spectroscopically.

View Article and Find Full Text PDF

Purpose Of Review: Over the last 2 decades, integrative oncology (IO) has seen exponential growth within cancer care. It aims to combine evidence-based complementary therapies with conventional treatments to improve the well-being and quality of life for individuals dealing with cancer. The proliferation of integrative medicine programs in major cancer centers globally reflects varying approaches shaped by cultural, demographic, and resource-based factors.

View Article and Find Full Text PDF

Telecommunications technology began to be integrated into health care delivery by the mid-1900s, with the goal of increasing access to care including access to cancer care.There have been at least 3 significant telehealth expansion periods, with the most recent related to the COVID-19 pandemic. Technology uptake increased in the 1990s as quality improved, costs came down, and usability factors were addressed.

View Article and Find Full Text PDF

Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control.

View Article and Find Full Text PDF

Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to test if a sleep-light intervention that alters melatonin rhythms can help improve depression in perimenopausal and postmenopausal women.
  • Two different intervention strategies were implemented: one that advanced sleep and provided morning bright light, and another that delayed sleep with evening light exposure for comparison among depressed participants and controls.
  • Results showed that the phase-advance intervention significantly improved mood and advanced melatonin secretion timing in depressed participants, suggesting that adjusting melatonin rhythms could be beneficial for mental health in this demographic.
View Article and Find Full Text PDF

Integrativety oncology (IO) is a "patient-centered, evidence-informed field of comprehensive cancer care that utilizes mind-body practices, natural products, and lifestyle modifications from different traditions alongside conventional cancer treatments." There is an urgent need to educate oncology health care providers on the fundamentals of evidence-based IO to meet the needs of people with cancer. In this chapter, we aim to provide oncology professionals with actionable guidance on the basis of the Society for Integrative Oncology (SIO)-American Society of Clinical Oncology (ASCO) guidelines on integrative medicine use during oncology visits to help alleviate symptoms and side effects in people with cancer during and after treatment.

View Article and Find Full Text PDF

Background: Cancer survivors represent one of the fastest growing populations in the United States. Unfortunately, nearly 1 in 3 survivors experience anxiety symptoms as a long-term consequence of cancer and its treatment. Characterized by restlessness, muscle tension, and worry, anxiety worsens the quality of life; impairs daily functioning; and is associated with poor sleep, depressed mood, and fatigue.

View Article and Find Full Text PDF
Article Synopsis
  • * Using national samples of 107 oncology providers and 88 SGM patients, the study analyzed provider knowledge, attitudes, behaviors, and interactions with patients using various statistical methods.
  • * Results showed providers believed they were more affirming than patients felt they were, highlighting a disconnect in communication and understanding between patients and providers regarding SGM healthcare experiences.
View Article and Find Full Text PDF

The decision in overturned federal protections for abortion rights, making way for states to enact abortion bans with or without exceptions for the health or life of the pregnant patient. Patient care across many areas of medicine including oncology continues to be affected. Although the change in the legal landscape is widely felt, the core ethical considerations for physicians do not change because of restrictions on the practice of medicine.

View Article and Find Full Text PDF

Reactions of the hexahydride OsH(PPr) () with 2-butyne and 3-hexyne and the behavior of the resulting species toward pinacolborane (pinBH) have been investigated in the search for new hydroboration processes. Complex reacts with 2-butyne to give 1-butene and the osmacyclopropene OsH(η-CMe)(PPr) (). In toluene, at 80 °C, the coordinated hydrocarbon isomerizes into a η-butenediyl form to afford OsH(η-CHCHCHCH)(PPr) ().

View Article and Find Full Text PDF

The organic molecule 2-(1-phenyl-1-(pyridin-2-yl)ethyl)-6-(3-(1-phenyl-1-(pyridin-2-yl)ethyl)phenyl)pyridine () has been designed, prepared, and employed to synthesize the encapsulated-type -tris(heteroleptic) iridium(III) derivative Ir(κ-'L). Its formation takes place as a result of the coordination of the heterocycles to the iridium center and the -CH bond activation of the phenyl groups. Dimer [Ir(μ-Cl)(η-COD)] is suitable for the preparation of this compound of class [Ir(9h)] (9h = 9-electron donor hexadentate ligand), but Ir(acac) is a more appropriate starting material.

View Article and Find Full Text PDF

Background: Testing the hypothesis that combined wake + light therapy improves mood in pregnant vs. postpartum depressed participants (DP) by differentially altering melatonin and sleep timing.

Methods: Initially 89 women, 37 pregnant (21 normal controls-NC; 16 DP) and 52 postpartum (27 NCs; 25 DP), were randomized to a parallel trial of a phase-delay intervention (PDI): 1-night of early-night wake therapy (sleep 3-7 am) + 6-weeks of evening bright white light (Litebook Advantage) for 60 min starting 90 min before bedtime, vs.

View Article and Find Full Text PDF

To test the hypothesis that 1 week of combined sleep and light interventions (SALI), which phase-advance (shift earlier) melatonin circadian rhythms, improves mood significantly more than phase-delay (shift later) SALI. After a 2-month diagnostic evaluation for premenstrual dysphoric disorder (PMDD per DSM-5 criteria) in a university clinical research setting, 44 participants enrolled in baseline studies were randomized in the luteal phase at home to (A) a phase-advance intervention (PAI): 1 night of late-night wake therapy (LWT: sleep 9 pm-1 am) followed by 7 days of the morning (AM) bright white light (BWL), or (B) a phase-delay intervention (PDI): 1 night of early-night wake therapy (EWT: sleep 3-7 am) plus 7 days of the evening (PM) BWL. After a month of no intervention, participants underwent the alternate intervention.

View Article and Find Full Text PDF